China vs North Macedonia: Protecting minority investors: Ease of shareholder suits index (0-10)
China
40
in 2013
North Macedonia
40
in 2013
China rank
132nd
North Macedonia rank
132nd
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- China
- North Macedonia
How they compare
China currently reports 40 against 40 in North Macedonia, a difference of 0.
The two have swapped places 2 times across 9 shared years of data; in 2005 it was North Macedonia ahead.
China ranks 132nd and North Macedonia ranks 132nd of 191 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36 | 30 | 6 | China |
| 2010s | 40 | 32.5 | 7.5 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), China or North Macedonia?
- China, at 40 against 40 in North Macedonia as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between China and North Macedonia?
- 0, with China ahead.
- How many years of comparable data are there for China and North Macedonia?
- 9 years are reported by both, from 2005 to 2013.
- How do China and North Macedonia rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- China ranks 132nd and North Macedonia ranks 132nd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.